Table 2. | A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control

Open accessCopyright infoDownload PDF

A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control

Table 2.

Affiliation details

École Polytechnique Fédérale de Lausanne, Switzerland; University Hospital and University of Lausanne, Switzerland; Eötvös Loránd University and the Hungarian Academy of Sciences, Hungary; Swiss Institute of Bioinformatics, Switzerland; Microsoft Research, United States; BC Centre for Excellence in HIV/AIDS, Canada; Simon Fraser University, Canada; Murdoch University, Australia; Vanderbilt University Medical Center, United States; Universitat Autònoma de Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Spain; Instituto de Salud Carlos III, Spain; University of Bern & Inselspital, Switzerland; University Hospital and University of Zürich, Switzerland; Regional Hospital of Lugano, Switzerland; Cantonal Hospital, Switzerland; University of Basel, Switzerland; Geneva University Hospitals, Switzerland; St. Petersburg State University, Russia; Massachusetts General Hospital, United States; University of British Columbia, Canada
Table 2.

Distribution of samples across genotyping platforms and cohorts

DOI: http://dx.doi.org/10.7554/eLife.01123.007

NGenotyping platformCohort
140Illumina 1MACTG
6Illumina OmniExpress 12v1HCARLOS III
518Affymetrix 6.0HOMER
136Illumina OmniExpress12v1HHOMER
47Illumina 650kIHCS
6Illumina 660W-QuadIRSICAIXA
2Illumina 1MSHCS
79Illumina 550kSHCS
122Illumina OmniExpress12v1HSHCS
15Illumina 550kWAHCS
  • ACTG = AIDS Clinical Trials Group Network; CARLOS III = Instituto de Salud Carlos III; HOMER = HAART Observational Medical Evaluation and Research Study; IHCS = International HIV Controllers Study; IRSICAIXA = AIDS Research Institute IrsiCaixa; SHCS = Swiss HIV Cohort Study; WAHCS = Western Australian HIV Cohort Study.